Regression of hypertrophy in remote myocardium after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: A magnetic resonance imaging follow-up study

被引：0
|
作者：
van Dockum, WG
Gotte, MJW
Beek, AM
ten Cate, FJ
ten Berg, JM
Hofman, MBM
Visser, CA
van Rossum, AC
机构：
[1] VU Univ, Med Ctr, Amsterdam, Netherlands
[2] Erasmus Med Ctr, Rotterdam, Netherlands
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2004年 / 43卷 / 05期
关键词：
D O I：
10.1016/S0735-1097(04)90704-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：166A / 166A
页数：1
相关论文
共 50 条
  • [41] Follow-Up of Up to 25 Years After Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy
    Veselka, Josef
    Tesar, David
    Topalo, Robert
    Hansvenclova, Eva
    Adlova, Radka
    JACC-CARDIOVASCULAR INTERVENTIONS, 2023, 16 (12) : 1556 - 1557
  • [42] Mid-term follow-up after transluminal alcohol septal ablation of hypertrophic obstructive cardiomyopathy. A real world study
    Chawla, Kamaldeep
    Lefevre, Thierry
    Morice, Marie-Claude
    Khand, Aleem
    Laurent, Ivan
    Malergue, Marie-Christine
    Cormier, Bertrand
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : B70 - B70
  • [43] Changes in vortex and systolic anterior motion after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy
    Shirakura, Satoshi
    Hayama, Hiromasa
    Hara, Hisao
    Kawakami, Yoshihisa
    Doi, Seiichi
    Yoshida, Shigehisa
    Hiroi, Yukio
    JOURNAL OF ECHOCARDIOGRAPHY, 2023, 22 (3) : 171 - 172
  • [44] Clinical characteristics and cardiac magnetic resonance for the patients received repeat percutaneous transluminal septal myocardial ablation in refractory hypertrophic obstructive cardiomyopathy
    Kitamura, M.
    Amano, Y.
    Shibuya, J.
    Matsuda, J.
    Nakamura, S.
    Takano, H.
    Asai, K.
    Takayama, M.
    Shimizu, W.
    EUROPEAN HEART JOURNAL, 2014, 35 : 1084 - 1084
  • [45] Myocardial perfusion after percutaneous transluminal septal myocardial ablation as assessed by myocardial contrast echocardiography in patients with hypertrophic obstructive cardiomyopathy
    Pedone, Chiara
    Biagini, Elena
    Galema, Tjebbe W.
    Vletter, Willem B.
    ten Cate, Folkert J.
    JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY, 2006, 19 (08) : 982 - 986
  • [46] Morrow septal myectomy and percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy, a single centre comparison
    Scholzel, B. E.
    Swaans, M. J.
    Idzerda, H. H. D.
    Bergmeijer, T.
    Kelder, J. C.
    Yilmaz, A.
    Schepens, M. A. A. M.
    Ten Berg, J. M.
    EUROPEAN HEART JOURNAL, 2008, 29 : 56 - 56
  • [47] Long term follow up of percutaneous transluminal septal myocardial ablation (PTSMA) for hypertrophic obstructive cardiomyopathy (HOCM) confirms the safety and clinical benefits
    Jensen, M.
    Havndrup, O.
    Joergensen, E.
    Helquist, S.
    Kelbaek, H.
    Koeber, L.
    Hassager, C.
    Bundgaard, H.
    EUROPEAN HEART JOURNAL, 2008, 29 : 54 - 55
  • [48] One-year follow-up after echocardiographically-guided percutaneous septal ablation in hypertrophic obstructive cardiomyopathy
    Seggewiss, H
    Faber, L
    Ziemssen, P
    Gleichmann, U
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2001, 126 (15) : 424 - 430
  • [49] Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy - Results with respect to intraprocedural myocardial contrast echocardiography
    Faber, L
    Seggewiss, H
    Gleichmann, U
    CIRCULATION, 1998, 98 (22) : 2415 - 2421
  • [50] Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: Identification of the target vessel by myocardial contrast echocardiography
    Faber, L
    Seggewiss, H
    Fassbender, D
    Strick, S
    Bogunovic, N
    Gleichmann, U
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (02) : 202A - 202A
12345